InvestorsHub Logo
icon url

changes_iv

10/24/13 9:08 PM

#75736 RE: ZincFinger #75735

I figure the sponsor (NNVC) got it in writing. What if the consultants like what they see in studies results/data? What then? Would they, like Patric Cox, resign in order to buy stock?

Now, for all we know, NNVC is in the process of producing sufficient quantities of FluCide (reproducible)final candidate. However, this does not mean BASi is waiting with arms crossed for NanoViricides, Inc. to provide the first batch, meaning they are working on other projects. Maybe Tox and Safety studies have begun (to be announced Monday?). If not perhaps they could begin next week if BASi is open for the project to start. Possible?

BASi was with Nanoviricides, Inc. in the pre-IND meeting and the US FDA gave guidance beyond their documents. Is it possible that BASi's GLP Tox and Safety Studies were modified and shortened?

I know, we are not FAST TRACKed yet but thinking US FDA has gone way beyond their documents, even before fast-tracking further.